| Seq |
Description |
Document |
Type |
Size |
| 1 |
QUARTERLY REPORT |
f10q0617_actiniumpharma.htm |
10-Q |
585016 |
| 2 |
ASSIGNMENT AND CONSENT AGREEMENT, DATED JUNE 6, 2017, AMONG 275 MADISON AVENUE R |
f10q0617ex10i_actinium.htm |
EX-10.1 |
38480 |
| 3 |
AMENDED AND RESTATED LICENSE AGREEMENT, DATED JUNE 8, 2017, BETWEEN ACTINIUM PHA |
f10q0617ex10iii_actinium.htm |
EX-10.3 |
28405 |
| 4 |
OFFER LETTER; DATED MAY 26, 2017, BY AND BETWEEN ACTINIUM PHARMACEUTICALS, INC. |
f10q0617ex10iv_actinium.htm |
EX-10.4 |
75592 |
| 5 |
AMENDED AND RESTATED AT-THE-MARKET MARKET ISSUANCE SALES AGREEMENT, DATED JULY 3 |
f10q0617ex10v_actinium.htm |
EX-10.5 |
308192 |
| 6 |
AGREEMENT, DATED JUNE 6, 2017, BY AND BETWEEN ACTINIUM PHARMACEUTICALS, INC. AND |
f10q0617ex10vi_actinium.htm |
EX-10.6 |
19359 |
| 7 |
CONSULTING AGREEMENT, DATED MAY 22, 2017, BY AND BETWEEN ACTINIUM PHARMACEUTICAL |
f10q0617ex10vii_actinium.htm |
EX-10.7 |
73017 |
| 8 |
SEPARATION AND SETTLEMENT AGREEMENT, DATED MAY 12, 2017, BY AND BETWEEN ACTINIUM |
f10q0617ex10viii_actinium.htm |
EX-10.8 |
64470 |
| 9 |
SEPARATION AND SETTLEMENT AGREEMENT, DATED MAY 12, 2017, BY AND BETWEEN ACTINIUM |
f10q0617ex10ix_actinium.htm |
EX-10.9 |
55112 |
| 10 |
CERTIFICATION |
f10q0617ex31i_actiniumpharm.htm |
EX-31.1 |
12014 |
| 11 |
CERTIFICATION |
f10q0617ex31ii_actiniumpharm.htm |
EX-31.2 |
12995 |
| 12 |
CERTIFICATION |
f10q0617ex32i_actiniumpharm.htm |
EX-32.1 |
4843 |
| 13 |
CERTIFICATION |
f10q0617ex32ii_actiniumpharm.htm |
EX-32.2 |
5937 |
| 20 |
GRAPHIC |
ex10iv_01.jpg |
GRAPHIC |
12711 |
| |
Complete submission text file |
0001213900-17-008244.txt |
|
3915054 |
